ColoHealth
Commercial- Indications
- Colorectal cancer
Company intelligence / Profile preview
New Day Diagnostics
Knoxville, Tennessee, United Statesedpbiotech.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
New Day Diagnostics has commercialized blood-based colorectal cancer screening tests and point-of-care diagnostics for various indications. Their clinical research includes a published study validating their colorectal cancer biomarker algorithm in collaboration with Abbott Laboratories and Copenhagen University Hospital involving nearly 2,000 patients. The company is expanding its pipeline following the acquisition of Epigenomics AG’s assets, aiming to relaunch FDA-cleared technologies and develop next-generation multiomic panels.
- Therapeutic areas
- OncologyRheumatologyGastroenterologyInfectious Diseases
- Modalities
- In vitro diagnosticsBlood-based biomarkersMultiomic panels
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Hepion Pharmaceuticals – licensing agreement for celiac disease diagnostic tests in EU and US marketsAbbott Laboratories – research collaboration on colorectal cancer screening algorithm validation
Beyond the preview
Go deeper on New Day Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New Day Diagnostics.